A retrospective cohort study found that attempting prompt cardioversion for early sustained atrial fibrillation recurrence ...
A multicenter randomized controlled clinical trial confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation; however, an ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
Recent-onset atrial fibrillation, defined as an onset within one week, is a major issue in clinical practice, and recent advances have shown that cardioversion to normal sinus rhythm provides better ...
A systematic review indicates that restoring sinus rhythm before catheter ablation is associated with lower recurrence in ...
A 70-year-old man comes to the clinic for routine follow-up of hypertension and is found to have new atrial fibrillation of unknown duration. Atrial fibrillation increases the risk of mortality and ...
Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...
ROME -- Edoxaban (Savaysa) appears at least as safe as the standard warfarin (Coumadin)/enoxaparin (Lovenox) strategy for use in bridging anticoagulation around cardioversion for recent onset atrial ...
Newswise — A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results